Terms: = Head and neck cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT AND Treatment
9 results:
1. Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung cancer from Phase III Lung-MAP S1400I Trial.
Parra ER; Zhang J; Duose DY; Gonzalez-Kozlova E; Redman MW; Chen H; Manyam GC; Kumar G; Zhang J; Song X; Lazcano R; Marques-Piubelli ML; Laberiano-Fernandez C; Rojas F; Zhang B; Taing L; Jhaveri A; Geisberg J; Altreuter J; Michor F; Provencher J; Yu J; Cerami E; Moravec R; Kannan K; Luthra R; Alatrash G; Huang HH; Xie H; Patel M; Nie K; Harris J; Argueta K; Lindsay J; Biswas R; Van Nostrand S; Kim-Schulze S; Gray JE; Herbst RS; Wistuba II; Gettinger S; Kelly K; Bazhenova L; Gnjatic S; Lee JJ; Zhang J; Haymaker C
Clin Cancer Res; 2024 Apr; 30(8):1655-1668. PubMed ID: 38277235
[TBL] [Abstract] [Full Text] [Related]
2. Loss of lrp1b expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.
Shaikh MH; Dawson A; Prokopec SD; Barrett JW; Y F Zeng P; Khan MI; Ryan SEB; Cecchini M; Palma DA; Mymryk JS; Boutros PC; Nichols AC
Oral Oncol; 2023 Nov; 146():106580. PubMed ID: 37778229
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma.
Lin LH; Chang KW; Cheng HW; Liu CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553
[TBL] [Abstract] [Full Text] [Related]
4. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma.
Loh JW; Lee JY; Lim AH; Guan P; Lim BY; Kannan B; Lee ECY; Gu NX; Ko TK; Ng CC; Lim JCT; Yeong J; Lim JQ; Ong CK; Teh BT; Chan JY
Commun Biol; 2023 Apr; 6(1):461. PubMed ID: 37106027
[TBL] [Abstract] [Full Text] [Related]
5. Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Xu J; Wang R; Wang T; Wang T; Gu D; He Y; Shu Y; Chen R; Liu L
Oral Oncol; 2021 Aug; 119():105369. PubMed ID: 34098386
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal cancer.
Lu G; Chen L; Wu S; Feng Y; Lin T
Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
[TBL] [Abstract] [Full Text] [Related]
7. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations.
Chang J; Tan W; Ling Z; Xi R; Shao M; Chen M; Luo Y; Zhao Y; Liu Y; Huang X; Xia Y; Hu J; Parker JS; Marron D; Cui Q; Peng L; Chu J; Li H; Du Z; Han Y; Tan W; Liu Z; Zhan Q; Li Y; Mao W; Wu C; Lin D
Nat Commun; 2017 May; 8():15290. PubMed ID: 28548104
[TBL] [Abstract] [Full Text] [Related]
8. Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.
Nakagawa T; Pimkhaokham A; Suzuki E; Omura K; Inazawa J; Imoto I
Cancer Sci; 2006 Oct; 97(10):1070-4. PubMed ID: 16918994
[TBL] [Abstract] [Full Text] [Related]
9. Frequent silencing of low density lipoprotein receptor-related protein 1B (lrp1b) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
[TBL] [Abstract] [Full Text] [Related]
